Percutaneous implantable nuclear prosthesis

Information

  • Patent Grant
  • 11638649
  • Patent Number
    11,638,649
  • Date Filed
    Friday, April 26, 2019
    5 years ago
  • Date Issued
    Tuesday, May 2, 2023
    a year ago
Abstract
A multi-chamber balloon for a nuclear implant has an elastomeric membrane defining inner and outer chambers integral with a valve body. The valve body includes a core portion and sealing membrane for sealing the inner and outer chambers. An assembly for manufacturing the multi-chamber balloon includes a balloon mandrel which may be dip coated in a silicone dispersion to create an elastomeric membrane for the inner and outer chambers integral with the valve body. The elastomeric membrane formed on the mandrel is partially inverted to form a coaxial elastomeric structure with the smaller inner chamber disposed within the larger outer chamber. The valve is incorporated into the inner and outer chambers to form a unitary structure.
Description
BACKGROUND
1. Field of the Invention

This application relates generally to methods and devices for repairing an intervertebral disc. More specifically, the application relates to a percutaneously deployed implantable disc replacement and methods for manufacturing such a disc replacement/prosthesis.


2. Description of Related Art

A common medical issue is back pain due to spinal disc injuries caused by trauma, the aging process or other disorders. One method of treatment that has been proposed is to remove the existing nucleus pulposus and replace it with a nuclear prosthesis formed in situ using open surgery or minimally invasive surgical techniques. One proposed method comprises the steps of (i) providing a mold, such as a balloon, to contain a flowable curable material that can cure in situ within the disc space, (ii) providing a conduit to connect the mold cavity to a source of flowable curable material, (iii) delivering the flowable curable material into the mold to fill the cavity, and (iv) permitting the curable material to cure.


The existing techniques for forming a nuclear prosthesis in situ have not achieved convincing clinical acceptance or commercial success. One problem identified by the present inventors is the substantial difference in the modulus of elasticity between the vertebral bony elements, including the vertebral end plates, and the annulus fibrosus on the one hand, and the implanted elements on the other. The high modulus of elasticity of the implanted material is disadvantageous since it does not dampen impacts or sudden increases in intradiscal pressure during extreme bending or torsion, especially during high loading peaks. The large difference in the modulus of elasticity between implanted disc materials and adjacent tissues can also lead to softening of the vertebral end plates and adjacent bone (spongeosus), resulting in subsidence of the nuclear implant. Migration and expulsion of the implant can also occur.


Therefore, there is a need for an improved nuclear implant.


SUMMARY

An object of exemplary embodiments of the present invention is to provide a method of manufacturing an elastomeric enclosure for a multi-chamber nuclear implant that can selectively and controllably be inflated and deflated with materials that, together, provide physical and mechanical properties similar to those of a normal disc, and which can be tailored to individual patient parameters.


Another object of exemplary embodiments of the present invention is to provide a method of fabricating a nuclear implant that can be deployed percutaneously in a disc cavity and inflated to conform to the shape and size of the disc cavity.


A further object of exemplary embodiments of the present invention is to provide a nuclear implant which reinforces the annulus fibrosus if it is torn.


According to an exemplary embodiment, an implantable prosthetic device comprises an inner inflatable enclosure having a first opening and an outer inflatable enclosure having a first opening. The outer inflatable enclosure encapsulates the inner inflatable enclosure. A valve assembly sealingly couples the first opening of the outer inflatable enclosure and the first opening of the inner inflatable enclosure, and the valve assembly is configured to allow independent inflation of the outer and inner inflatable enclosures. An annular reinforcement band is provided around the periphery of the outer inflatable enclosure. When implanted, the inner chamber is filled with a compressible material and the outer inflatable enclosure is filled with an in situ curable material, such as silicone. This structure allows for vertical and horizontal load stresses placed on the implant to be redirected inward, centrally toward the inner compressible enclosure instead of outward.


The inner and outer inflatable enclosures may comprise a seamless, unitary piece of material. The inner inflatable enclosure may have a second opening generally opposite of the first opening, the outer inflatable enclosure may have a second opening generally opposite of the first opening, and a plug may sealingly couple the second opening of the inner inflatable enclosure and the second opening of the outer inflatable enclosure. The plug may be coupled to a neck portion of the second opening of the outer inflatable enclosure. The plug and the neck portion of the second opening of the outer inflatable enclosure may be coupled to a neck portion of the second opening of the inner inflatable enclosure.


The annular reinforcement band may be placed into the second opening of the inner inflatable enclosure and then the distal plug may be inserted into the second opening to couple the reinforcement band to the balloon. The reinforcement band may be coupled to the inflatable enclosure at only one location, such as at the plug. A fastener may be provided to fasten the reinforcement band to the plug. The reinforcement band may include a shape memory material. The annular reinforcement band may comprise a tubular braid enclosing the shape memory material.


The valve assembly may comprise a valve core coupling the first openings of the outer and inner inflatable enclosures. The valve core has an opening from an interior of the valve core to an exterior of the valve core. A valve membrane partially envelops the valve core and has an opening into the outer inflatable enclosure. The opening in the valve membrane and the valve core are separated from one another to allow material to flow into the outer inflatable enclosure, while preventing backflow. The valve core may further comprise a resealable, puncturable membrane to provide access to the inner inflatable enclosure.


The valve membrane and the valve core may be integrally molded, or the valve core may be bonded to the valve membrane with an adhesive.


The inner and outer inflatable enclosures may comprise an elastomer, such as silicone rubber.


In some embodiments, a curable material may be provided to inflate the outer inflatable enclosure, and a compressible material such as gas may be provided to inflate the inner inflatable enclosure to allow the cured material to deform. The cured material may substantially surround the inner inflatable enclosure. In other embodiments, an incompressible material (e.g., a liquid) is provided to inflate the inner inflatable enclosure and then the curable material is injected into the outer inflatable enclosure. The incompressible material is then removed from the inner inflatable enclosure and replaced with a compressible material (e.g., a gas). In certain embodiments, the curable material further polymerizes with the inner and outer inflatable enclosures to form a solid, unitary member.


In accordance with an exemplary embodiment, a valve assembly for inflating an implantable prosthetic device comprising an inner inflatable enclosure connected to an outer inflatable enclosure comprises an elastomeric membrane forming a passageway from an interior of the inner inflatable enclosure to an exterior of the outer inflatable enclosure and a valve core disposed in the passageway so that the elastomeric membrane surrounds the valve core. The elastomeric membrane has an opening into an interior of the outer inflatable enclosure, and the elastomeric membrane surrounds the valve core. The valve core comprises a conduit extending from a first end to a second end, and a resealable, puncturable membrane at the second end of the valve core conduit for providing resealable access to the inner inflatable enclosure. An opening in the conduit extends from an interior of the conduit to an exterior of the conduit, and the opening in the valve core is offset from the opening in the elastomeric membrane to form a one way valve allowing material introduced into the interior of the conduit to pass into the interior of the outer inflatable enclosure while preventing backflow.


In accordance with an exemplary embodiment, a method of implanting a prosthetic device into an intervertebral space having a nucleus pulposus surrounded by an annulus fibrosus comprises penetrating the annulus fibrosus, removing the nucleus pulposus, and implanting an implantable prosthetic device, wherein the implantable prosthetic device comprises an inner inflatable enclosure having a first opening and an outer inflatable enclosure having a first opening. The outer inflatable enclosure encapsulates the inner inflatable enclosure. A valve assembly sealingly couples the first opening of the outer inflatable enclosure and the first opening of the inner inflatable enclosure, and the valve assembly is configured to allow independent inflation of the outer and inner inflatable enclosures. A reinforcement band is provided around the periphery of the outer inflatable enclosure.


In some embodiments, the method may further comprise inflating the inner inflatable enclosure using a compressible material, and the compressible material may comprise a gas. The method may further comprise inflating the outer inflatable enclosure using a curable material, and the curable material may be silicone rubber. In other embodiments, the method may further comprise inflating the inner inflatable enclosure using an incompressible material, and the incompressible material may comprise a liquid. The method may further comprise inflating the outer inflatable enclosure using a curable material, allowing the curable material to cure, and then replacing the incompressible material in the inner inflatable enclosure with a compressible material.


In accordance with an exemplary embodiment, a method of producing an implantable prosthetic device comprises (i) injection molding a prosthesis blank comprising an outer membrane section with a proximal end and a distal end, an inner membrane section with a proximal end and a distal end, a valve section disposed between the proximal end of the outer membrane section and the proximal end of the inner membrane section, a distal plug inner section at the distal end of the inner membrane section, and a distal plug outer section at the distal end of the outer membrane section; and (ii) partially inverting the prosthesis blank so that the outer membrane section encloses the inner membrane section to form an outer balloon surrounding an inner balloon formed by the inner membrane.


In accordance with an exemplary embodiment, a method of producing an implantable prosthetic device comprises (i) providing a mandrel with a profiled outer surface configured to form a prosthesis blank comprising an outer membrane section with a proximal end and a distal end, an inner membrane section with a proximal end and a distal end, a valve section disposed between the proximal end of the outer membrane section and the proximal end of the inner membrane section, a distal plug inner section at the distal end of the inner membrane section, and a distal plug outer section at the distal end of the outer membrane section; (ii) coating the mandrel with a material to form the prosthesis blank; (iii) stripping the prosthesis blank from the mandrel; and (iv) partially inverting the prosthesis blank so that the outer membrane section encloses the inner membrane section to form an outer balloon surrounding an inner balloon formed by the inner membrane.


The mandrel may comprise a unitary body, and the valve section of the mandrel may comprise a valve core that is integrally molded with the prosthesis blank. The mandrel may comprise two separable pieces coupled to the valve core, and the step of stripping the prosthesis blank from the mandrel may comprise separating the mandrel pieces from the valve core and removing the separable pieces from the prosthesis blank.


The valve core may be glued into the valve section.


The distal plug may be inserted into the distal plug outer section to seal the distal plug outer section, and the distal plug and distal plug outer section may be inserted into the distal plug inner section.


A reinforcing band may be joined to the distal plug, and the reinforcing band, distal plug, and distal plug outer section may be inserted into the distal plug inner section. The reinforcing band may be joined to the distal plug with a fastener.


The mandrel may be coated by dipping it into a polymer liquid, which may comprise a silicone dispersion, and dried.


The elastomeric membrane may be stripped from the mandrel by melting the mandrel, or the prosthesis blank may be removed from the mandrel by stretching it over the mandrel. A reinforcing band may be applied around the periphery of the outer balloon.


In accordance with an exemplary embodiment, a mandrel for producing an implantable prosthetic device comprises a first balloon mandrel with a profiled outer surface configured in the shape of a first balloon; a second balloon mandrel with a profiled outer surface configured in the shape of a second balloon; and a valve core disposed between the first and second balloon mandrels. The outer surface of the first balloon mandrel may further comprises a distal opening section, and the outer surface of the second balloon mandrel may further comprise a distal opening section. The outer surfaces of the balloon mandrels may be curved. The outer surfaces of each of the balloon mandrels may comprise a central section with a generally uniform diameter.


In accordance with an exemplary embodiment, a mandrel for producing an implantable prosthetic device comprises a unitary body with a profiled outer surface. The profiled outer surface has an outer membrane section configured to form an annular balloon with a proximal end and a distal end; an inner membrane section configured to form a nuclear balloon with a proximal end and a distal end; a valve section configured to receive a valve assembly disposed between the proximal end of the outer membrane section and the proximal end of the inner membrane section; a distal plug outer section configured to receive a distal plug at the distal end of the outer membrane section; and a distal plug inner section configured to receive an assembly of the distal plug and distal plug outer section at the distal end of the inner membrane section.


The term “coupled” is defined as connected, although not necessarily directly. The terms “a” and “an” are defined as one or more unless this disclosure explicitly requires otherwise. The terms “substantially,” “approximately,” and “about” are defined as largely but not necessarily wholly what is specified (and includes what is specified; e.g., substantially 90 degrees includes 90 degrees and substantially parallel includes parallel), as understood by a person of ordinary skill in the art. In any disclosed embodiment, the terms “substantially,” “approximately,” and “about” may be substituted with “within [a percentage] of” what is specified, where the percentage includes 0.1, 1, 5, and 10 percent.


The terms “comprise” (and any form of comprise, such as “comprises” and “comprising”), “have” (and any form of have, such as “has” and “having”), “include” (and any form of include, such as “includes” and “including”) and “contain” (and any form of contain, such as “contains” and “containing”) are open-ended linking verbs. As a result, a system, or a component of a system, that “comprises,” “has,” “includes” or “contains” one or more elements or features possesses those one or more elements or features, but is not limited to possessing only those elements or features. Likewise, a method that “comprises,” “has,” “includes” or “contains” one or more steps possesses those one or more steps, but is not limited to possessing only those one or more steps. Additionally, terms such as “first” and “second” are used only to differentiate structures or features, and not to limit the different structures or features to a particular order.


A device, system, or component of either that is configured in a certain way is configured in at least that way, but it can also be configured in other ways than those specifically described.


Any embodiment of any of the systems and methods can consist of or consist essentially of—rather than comprise/include/contain/have—any of the described elements, features, and/or steps. Thus, in any of the claims, the term “consisting of” or “consisting essentially of” can be substituted for any of the open-ended linking verbs recited above, in order to change the scope of a given claim from what it would otherwise be using the open-ended linking verb.


The feature or features of one embodiment may be applied to other embodiments, even though not described or illustrated, unless expressly prohibited by this disclosure or the nature of the embodiments.


Details associated with the embodiments described above and others are presented below.





BRIEF DESCRIPTION OF DRAWINGS


FIG. 1 is a perspective view of an inflated implant in accordance with an embodiment of the present invention;



FIG. 2 is a perspective view of the inflated implant of FIG. 1 from another direction;



FIG. 3 is a top view of the implant of FIG. 1;



FIG. 4 is a sectional view taken through line 4-4 in FIG. 2;



FIG. 5 is a sectional view taken through line 5-5 in FIG. 2;



FIG. 6 is a cut-away view of a portion of an implant valve of the implant of FIG. 1;



FIG. 7 is a cut-away view of a portion of the implant valve of FIG. 6;



FIG. 8 is a sectional view of an implant assembly prior to insertion of a distal plug and attachment of an annular reinforcing member;



FIG. 9 is a sectional view of a mandrel and implant according to an embodiment of the present invention;



FIG. 10 illustrates a first assembly step for the implant assembly of FIG. 1;



FIG. 11 illustrates a second assembly step for the implant assembly of FIG. 1;



FIG. 12 illustrates a third assembly step for the implant assembly of FIG. 1;



FIG. 13 illustrates a fourth assembly step for the implant assembly of FIG. 1;



FIG. 14 is a sectional view of a mandrel and implant assembly according to another embodiment of the present invention;



FIG. 15 illustrates a first assembly step for the implant assembly of FIG. 1;



FIG. 16 illustrates a second assembly step for the implant assembly of FIG. 1;



FIG. 17 illustrates a third assembly step for the implant assembly of FIG. 1;



FIG. 18 illustrates a fourth assembly step for the implant assembly of FIG. 1;



FIG. 19 illustrates a final assembly step for the implant assembly of FIG. 1;



FIG. 20 illustrates a first step in implanting the implant assembly of FIG. 1;



FIG. 21 illustrates a second step in implanting the implant assembly of FIG. 1;



FIG. 22 illustrates a third step in implanting the implant assembly of FIG. 1; and



FIG. 23 illustrates a fourth step in implanting the implant assembly of FIG. 1.





DETAILED DESCRIPTION

In the following detailed description, reference is made to the accompanying drawings, in which are shown exemplary but non-limiting and non-exhaustive embodiments of the invention. These embodiments are described in sufficient detail to enable those having skill in the art to practice the invention, and it is understood that other embodiments may be used, and other changes may be made, without departing from the spirit or scope of the invention. The following detailed description is, therefore, not to be taken in a limiting sense, and the scope of the invention is defined only by the appended claims. In the accompanying drawings, like reference numerals refer to like parts throughout the various figures unless otherwise specified.


Description of Implant


Referring to FIGS. 1-8, an embodiment of a percutaneously deliverable spinal implant 100 includes an outer inflatable enclosure (or balloon) 102 and an inner inflatable enclosure (or balloon) 104. Outer inflatable enclosure 102 forms an annular chamber 106, and inner inflatable enclosure 104 forms a nuclear chamber 108. Nuclear chamber 108 is encapsulated within annular chamber 106. Preferably, outer and inner inflatable enclosures 102, 104 are formed as a seamless, unitary piece of an elastomeric material, such as silicone rubber. The use of an elastomeric material produces compliant outer and inner balloons 102, 104. That is, the outer and inner balloons 102, 104 expand when internal pressure is applied. The use of compliant balloons provides certain advantages. Compliant balloons accommodate the irregular, flat or discoid configuration of the nuclear space. Furthermore, a compliant balloon maintains an appropriate modulus of elasticity of the nuclear implant following elastomeric curing, and preserve bio-mechanical mobility of the vertebral segment, and allows unhindered deformation of the cured silicone component into the central void.


An annular reinforcing band 110 may be disposed around the perimeter of the lateral edges of implant 100 to minimize or prevent over-stretching of the elastomeric membrane or over inflation of outer and inner balloons 102, 104 circumferentially. Annular reinforcement band 110 encourages vertical expansion to widen the disc space. The vertebral superior and inferior end plates constrain the expansion of the implant 100.


The size of implant 100 is selected so that it can be percutaneously inserted into a denucleated intervertebral disc space while deflated and then inflated to fill the denucleated cavity. In one embodiment, the exterior of inflated implant 100 is approximately 30 mm in length, 20 mm in width, and 10 mm in height, and the exterior of inner inflatable enclosure 104 is approximately 9 mm long, 6 mm wide, and 6 mm thick.


Annular reinforcing band 110 may be a biocompatible textile material. In one embodiment, annular reinforcing band 110 comprises a tubular, woven textile material. Annular reinforcing band 110 may also include an expandable member to provide additional support. The expandable member may be formed of a shape memory material, such as nitinol. U.S. Pat. No. 8,636,803, entitled Percutaneous Implantable Nuclear Implant, discloses one suitable construction of annular reinforcing band 110, and is hereby incorporated by reference in its entirety for all purposes.


Outer inflatable enclosure 102 has a first opening 118 and a second opening 120. Inner inflatable enclosure 104 has a first opening 136 and a second opening 138. A proximal plug, or valve core, 112 connects first opening 118 and first opening 136. A valve membrane 122 surrounds proximal plug 112 and cooperates with proximal plug 112 to form an inflation valve 124. Inflation valve 124 is a one-way valve which allows material to be introduced into annular chamber 106. Preferably, valve membrane 122 is formed integrally with outer and inner inflatable enclosures 102, 104, as will be described in further detail below. As seen most clearly in FIGS. 6-8, proximal plug 112 comprises a conduit 126 extending from a first end 128 to a second end 130. First end 128 of proximal plug 112 forms a port 114 for receiving an inflation stylus 116. Valve membrane 122 is coupled to proximal plug 112 by first and second adhesive bands 140, 142, which are substantially fluid tight. The portion of valve membrane 122 between first and second adhesive bands 140, 142 is unbonded to form a channel for allowing material to flow therethrough. At least one opening 132 extends from conduit 126 to the exterior of proximal plug 112. Valve membrane 122 has at least one opening 134 which is offset from opening 132. In this manner, when a suitable material (described in detail below) is introduced into conduit 126 under pressure, the material is introduced through opening 132 into annular chamber 106, stretches valve membrane 122, and flows out through opening 134. When pressure is removed from conduit 126, valve membrane 122 seals opening 132 and prevents backflow through opening 132. Second end 130 of conduit 126 is closed by a puncturable, resealable membrane 144.


A distal plug 146 is disposed in a neck portion 148 extending from second opening 138 of the inner inflatable enclosure 104. The distal plug 148 is bonded to the neck portion 148 to form a fluid tight seal. The distal plug 146 and neck portion 148 assembly is disposed within a neck portion 150 extending from second opening 120 of outer inflatable enclosure 102. Annular reinforcing band 110 may be trapped between the distal plug 146 and neck portion 148 assembly and the neck portion 150 to serve as an anchor for reinforcing band 110. Alternatively, a fastener 152 may be used to anchor annular reinforcing band 110 to distal plug 146, as seen most clearly in FIG. 9.


Method of Manufacturing the Implant


Referring to FIGS. 9-13, in one embodiment, inner and outer inflatable enclosures 102, 104 are formed from a unitary implant blank 154. Implant blank 154 may be produced by dip molding using a mandrel 156. Mandrel 156 comprises an outer membrane section 158, an inner membrane section 160, and a valve section 162. Mandrel 156 may be one piece or multiple pieces. In one embodiment, outer membrane section 158, inner membrane section 160, and valve section 162 are separate pieces which are assembled together. Mandrel 156 is dipped into a polymer liquid, such as a silicone dispersion, removed from the liquid and allowed to dry or cure. Mandrel 156 may be dipped one or more times to build up a desired thickness of material. The blank 154 comprises neck portion 150, outer inflatable enclosure 102, valve membrane 122, inner inflatable enclosure 104, and neck portion 148.


After curing or drying, implant blank 154 is stripped from mandrel 156. This may be accomplished by stretching implant blank 154 over mandrel 156. If mandrel 156 is composed of separable pieces, it may be disassembled prior to stripping. In one embodiment, mandrel 156 may be formed of a meltable or dissolvable material and melted or dissolved to strip implant blank 154 from mandrel 156. Opening 134 through valve membrane 122 is formed in implant blank 154.


Referring to FIGS. 10-13, implant blank 154, distal plug 146 and proximal plug (or valve core) 112 are provided. Neck portion 148 which extends from inner inflatable enclosure 104 is inverted into the interior of inner inflatable enclosure 104 and distal plug 146 is inserted into neck portion 148 and glued into place. The neck portion is the further inverted into the annular chamber 106. Next, proximal plug 112 is inserted and glued into the valve membrane 122. This is done in two steps. First, the end of proximal plug 112 nearest the annular chamber 106 is glued to valve membrane 122 with first adhesive band 142. Next, the implant blank 154 is further inverted, and second adhesive band 142 is applied to glue implant blank 154 to the second end of proximal plug 112. This results in the configuration shown in FIG. 12. Next, neck portion 150 is tucked into outer inflatable enclosure 102 (as indicated by the arrows in FIG. 8) and over distal plug 146 and neck portion 148, as shown in FIG. 13. Annular reinforcing band 110 may be tucked in at the same time, or may be fastened to distal plug 146 by a fastener.


In another embodiment, implant blank 154 is formed by injection molding over a mandrel using conventional techniques. That is, the mandrel is placed into an injection mold having a cavity corresponding to the outer shape of the implant blank, and a curable material is injected into the mold under pressure. The curable material is allowed to cure, thereby forming implant blank 154 over the mandrel. The mandrel and implant blank 154 are then removed from the injection mold. Once implant blank 154 is formed, the remaining assembly steps are as described in the prior paragraph.



FIGS. 14-19 illustrate another method of making an implant 100. In this embodiment, a mandrel 164 comprises a first mandrel section 166 forming an outer membrane section 168 and a second mandrel section 168 forming an inner membrane section 170. First mandrel section 166 is inserted into valve core (or proximal plug) 112, and second mandrel section is mated with the other end of proximal plug 112. Referring to FIG. 15, the mandrel and valve assembly is then dip molded to form an implant blank 176. Referring to FIG. 16, the neck portion 188 of the implant blank 176 is inverted and a proximal plug is glued into the neck portion 188. A valve membrane 192 is applied over the plug section and adhered to the plug section with first and second adhesive bands to form an implant valve. The implant blank 176 is then inverted left to right over the valve core 112, as shown in FIG. 18. Finally, the neck portion 190 tucked into the outer inflatable enclosure 102. Annular reinforcing band 110 may be tucked in at the same time, or may be fastened to distal plug 146 by a fastener.


Method of Deploying an Implant


Referring to FIGS. 20-23, the inflatable implant 100 is particularly well suited for deployment using minimally invasive or percutaneous surgical techniques. To prepare the inflatable implant 100 for deployment, the implant is deflated and stretched to minimize its cross-sectional profile. An insertion stylus 116 is detachably inserted into port 114, then the implant 100 is inserted into a deployment cannula 180. Deployment cannula 180 has a minimal cross-sectional profile.


Referring to FIG. 20, to implant the inflatable implant 100, the existing nucleus pulposus is removed by performing a discectomy while leaving the annulus fibrosus 178 substantially intact. Preferably, the discectomy is performed using minimally invasive surgical techniques, such as percutaneous techniques, which leaves a small opening through the annulus fibrosus 178. Once the nucleus pulposus has been removed, the annulus fibrosus 178 and vertebral end plates 182, 184 form a substantially empty disc cavity 182.


After the nucleus pulposus has been removed, deployment cannula 180 with preloaded implant 100 is placed into the empty disc cavity 182. The implant 100 is deployed by pushing it out of the deployment cannula and into the empty disc cavity, as shown in FIG. 21. The implant 100 is in an uninflated state.


In one embodiment, nuclear chamber 108 is first inflated with a compressible fluid 194, such as a gas. This may be performed using a needle (not shown) which is delivered through the inflation stylus 116 and pushed through the puncturable, resealable membrane 144. The compressible fluid is deployed into the nuclear chamber 108 to inflate the inner inflatable enclosure 104. The pressure of the nuclear chamber 108 is selected so that it provides a buffer zone for inward deformation of the cured elastomer 186 during weight bearing and spine movement. Once nuclear chamber 108 is inflated to the desired pressure, the needle is withdrawn from nuclear chamber 108. In another embodiment, instead of using a removable needle, inflation stylus 116 may have a septum extending through the stylus to divide the stylus into two lumens. One lumen extends through resealable, puncturable membrane 144 into nuclear chamber 108, while the other lumen delivers an in situ curable material to implant valve 124 and annular chamber 106.


Inflation stylus 116 is used to deliver an in situ curable material to annular chamber 106 through the one way implant valve 124 (FIG. 22). The curable material is preferably an elastomeric material, such as silicone rubber, which further polymerizes with the material of inner and outer inflatable enclosures 102, 104 to form a unitary member. The modulus of elasticity and other characteristics of the curable material can be selected based upon patient specific parameters. For instance, younger, more active patients may require a firmer material than less mobile geriatric patients. Once annular chamber 106 is inflated to a desired pressure, inflation stylus 116 can be removed. Implant valve 124 prevents the curable material from leaking out of the annular chamber 106.


After the curable material is allowed to cured, the implant 100 comprises an annular ring of a cured elastomer 186 surrounding nuclear chamber 108 which is filled with a compressible material 194. This structure allows for vertical and horizontal load stresses placed on the intervertebral disc space to be redirected inward, centrally toward nuclear chamber 108 (see direction arrows of FIG. 23) instead of outward. Moreover, annular reinforcing band 110 encourages tissue in-growth of native annulus fibrosus 178, thereby providing reinforcement to native annulus fibrosus 178.


In another embodiment, nuclear chamber 108 is first inflated with an incompressible fluid, such as a liquid. This may be performed using a needle or an inflation stylus, as described above. Once nuclear chamber 194 is inflated, inflation stylus 116 is used to deliver an in situ curable material to annular chamber 106 through the one way implant valve 124. After the curable material is allowed to cured, the incompressible fluid is removed from nuclear chamber 108 and replaced with compressible material 194. This may be accomplished with a needle using implant valve 124.


The above specification and examples provide a complete description of the structure and use of exemplary embodiments. Although certain embodiments have been described above with a certain degree of particularity, or with reference to one or more individual embodiments, those skilled in the art could make numerous alterations to the disclosed embodiments without departing from the scope of this invention. As such, the various illustrative embodiments of the present devices are not intended to be limited to the particular forms disclosed. Rather, they include all modifications and alternatives falling within the scope of the claims, and embodiments other than the one shown may include some or all of the features of the depicted embodiment. For example, components may be combined as a unitary structure, and/or connections may be substituted (e.g., threads may be substituted with press-fittings or welds). Further, where appropriate, aspects of any of the examples described above may be combined with aspects of any of the other examples described to form further examples having comparable or different properties and addressing the same or different problems. Similarly, it will be understood that the benefits and advantages described above may relate to one embodiment or may relate to several embodiments.


The claims are not intended to include, and should not be interpreted to include, means-plus- or step-plus-function limitations, unless such a limitation is explicitly recited in a given claim using the phrase(s) “means for” or “step for,” respectively.

Claims
  • 1. An implantable prosthetic device comprising: an inner inflatable enclosure having a first opening and a second opening generally opposite of the first opening;an outer inflatable enclosure having a first opening and a second opening generally opposite of the first opening of the outer inflatable enclosure, the outer inflatable enclosure encapsulating the inner inflatable enclosure;a valve assembly sealingly coupled to the first opening of the outer inflatable enclosure and the first opening of the inner inflatable enclosure, the valve assembly being configured to allow independent inflation of the outer and inner inflatable enclosures;a plug sealingly couples the second opening of the inner inflatable enclosure and the second opening of the outer inflatable enclosure; anda reinforcement band around the periphery of the outer inflatable enclosure.
  • 2. The implantable prosthetic device of claim 1, wherein the inner and outer inflatable enclosures comprise a unitary piece of material.
  • 3. The implantable prosthetic device of claim 1, wherein the plug is coupled to a neck portion of the second opening of the outer inflatable enclosure.
  • 4. The implantable prosthetic device of claim 3, wherein the plug and the neck portion of the second opening of the outer inflatable enclosure are coupled to a neck portion of the second opening of the inner inflatable enclosure.
  • 5. The implantable prosthetic device of claim 4, wherein the reinforcement band is tucked into the second opening of the inner inflatable enclosure.
  • 6. The implantable prosthetic device of claim 1, wherein the reinforcement band is attached only to the plug.
  • 7. The implantable prosthetic device of claim 1, further comprising a fastener for fastening the reinforcement band to the plug.
  • 8. The implantable prosthetic device of claim 1, wherein the reinforcement band includes a shape memory material.
  • 9. The implantable prosthetic device of claim 8, wherein the reinforcement band further comprises a tubular braid enclosing the shape memory material.
  • 10. The implantable prosthetic device of claim 1, wherein the valve assembly comprises: a valve core having an opening from an interior of the valve core to an exterior of the valve core;a valve membrane coupling the first openings of the outer and inner inflatable enclosures, the valve membrane partially enveloping the valve core and having an opening into the outer inflatable enclosure, wherein the opening in the valve membrane and the valve core are separated from one another.
  • 11. The implantable prosthetic device of claim 10, wherein the valve core further comprises a resealable, puncturable membrane for accessing the inner inflatable enclosure.
  • 12. The implantable prosthetic device of claim 10, wherein the valve membrane and the valve core are integrally molded.
  • 13. The implantable prosthetic device of claim 10, wherein the valve core is bonded to the valve membrane with an adhesive.
  • 14. The implantable prosthetic device of claim 1, wherein the inner and outer inflatable enclosures comprise an elastomer.
  • 15. The implantable prosthetic device of claim 1, further comprising: a cured silicone material inflating the outer inflatable enclosure; anda compressible gas inflating the inner inflatable enclosure to allow the cured silicone material to deform.
  • 16. The implantable prosthetic device of claim 15, wherein the cured silicone material substantially surrounds the inner inflatable enclosure.
  • 17. The implantable prosthetic device of claim 15, wherein the cured silicone material further polymerizes with the inner and outer inflatable enclosures to form a solid member.
  • 18. A valve assembly for inflating an implantable prosthetic device comprising an inner inflatable enclosure connected to an outer inflatable enclosure; the valve assembly comprising: an elastomeric membrane forming a passageway from an interior of the inner inflatable enclosure to an exterior of the outer inflatable enclosure, the elastomeric membrane having an opening into an interior of the outer inflatable enclosure;a valve core disposed in the passageway so that the elastomeric membrane surrounds the valve core, the valve core comprising a conduit extending from a first end to a second end;a resealable, puncturable membrane at the second end of the conduit of the valve core for providing resealable access to the inner inflatable enclosure; andan opening in the conduit extending from an interior of the conduit to an exterior of the conduit; the opening in the conduit of the valve core being offset from the opening in the elastomeric membrane to form a one way valve allowing material introduced into the interior of the conduit to pass into the interior of the outer inflatable enclosure.
  • 19. An implantable prosthetic device comprising: an inner inflatable enclosure having a first opening and filled with a compressible gas;an outer inflatable enclosure having a first opening and filled with a cured silicone material, the outer inflatable enclosure substantially encapsulating the inner inflatable enclosure;a valve assembly sealingly coupled to the first opening of the outer inflatable enclosure and the first opening of the inner inflatable enclosure, the valve assembly comprising: a valve section disposed between a proximal end of the outer inflatable enclosure and a proximal end of the inner inflatable enclosure, wherein the valve section comprises a conduit having a sidewall with at least one opening extending through the sidewall; and, optionally,a reinforcement band around the periphery of the outer inflatable enclosure.
  • 20. The implantable prosthetic device of claim 19, wherein the inner inflatable enclosure has a second opening generally opposite of the first opening of the inner inflatable enclosure;the outer inflatable enclosure has a second opening generally opposite of the first opening of the outer inflatable enclosure; anda plug sealingly couples the second opening of the inner inflatable enclosure and the second opening of the outer inflatable enclosure.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a divisional of U.S. patent application Ser. No. 14/932,242 filed Nov. 4, 2015, which claims the benefit of priority of U.S. Provisional Patent Application No. 62/074,925, filed Nov. 4, 2014. The entire contents of each of the above-referenced applications are specifically incorporated herein by reference without disclaimer.

US Referenced Citations (286)
Number Name Date Kind
3875595 Froning Apr 1975 A
4187390 Gore Feb 1980 A
4478898 Kato Oct 1984 A
4517979 Pecenka May 1985 A
4619641 Schanzer Oct 1986 A
4743480 Campbell et al. May 1988 A
5123926 Pisharodi Jun 1992 A
5152782 Kowligi et al. Oct 1992 A
5181921 Makita et al. Jan 1993 A
5192310 Herweck et al. Mar 1993 A
5192326 Bao et al. Mar 1993 A
5437661 Rieser Aug 1995 A
5439464 Shapiro Aug 1995 A
5466509 Kowligi et al. Nov 1995 A
5571189 Kuslich Nov 1996 A
5628786 Banas et al. May 1997 A
5645597 Krapiva Jul 1997 A
5674295 Ray et al. Oct 1997 A
5702449 McKay Dec 1997 A
5752969 Cunci et al. May 1998 A
5827327 McHaney et al. Oct 1998 A
5860425 Benderev et al. Jan 1999 A
5865845 Thalgott Feb 1999 A
5879366 Shaw et al. Mar 1999 A
5888220 Felt Mar 1999 A
5888226 Rogozinski Mar 1999 A
5890268 Mullen et al. Apr 1999 A
5910277 Ishino et al. Jun 1999 A
5928284 Mehdizadeh Jul 1999 A
5935147 Kensey et al. Aug 1999 A
5954767 Pajotin et al. Sep 1999 A
5972022 Huxel Oct 1999 A
5976174 Ruiz Nov 1999 A
5981826 Ku et al. Nov 1999 A
5990378 Ellis Nov 1999 A
6001125 Golds et al. Dec 1999 A
6001130 Bryan et al. Dec 1999 A
6007570 Sharkey et al. Dec 1999 A
6007575 Samuels Dec 1999 A
6019793 Perren et al. Feb 2000 A
6036724 Lentz et al. Mar 2000 A
6079868 Rydell Jun 2000 A
6126682 Sharkey et al. Oct 2000 A
6127597 Beyar Oct 2000 A
6140452 Felt et al. Oct 2000 A
6146419 Eaton Nov 2000 A
6180848 Flament et al. Jan 2001 B1
6183518 Ross et al. Feb 2001 B1
6206921 Guagliano et al. Mar 2001 B1
6224630 Bao et al. May 2001 B1
6248131 Felt et al. Jun 2001 B1
6264695 Stoy Jul 2001 B1
6332894 Stalcup et al. Dec 2001 B1
6344054 Parodi Feb 2002 B1
6361637 Martin et al. Mar 2002 B2
6375682 Fleischmann et al. Apr 2002 B1
6390992 Morris et al. May 2002 B1
6395032 Gauchet May 2002 B1
6398803 Layne et al. Jun 2002 B1
6402750 Atkinson et al. Jun 2002 B1
6419704 Ferree Jul 2002 B1
6428576 Haldimann Aug 2002 B1
6436143 Ross et al. Aug 2002 B1
6443988 Felt et al. Sep 2002 B2
6482234 Weber et al. Nov 2002 B1
6527804 Gauchet et al. Mar 2003 B1
6533818 Weber et al. Mar 2003 B1
6582466 Gauchet Jun 2003 B1
6596008 Kambin Jul 2003 B1
6632235 Weikel et al. Oct 2003 B2
6645248 Casutt Nov 2003 B2
6673103 Golds et al. Jan 2004 B1
6689125 Keith et al. Feb 2004 B1
6712853 Kuslich Mar 2004 B2
6733532 Gauchet et al. May 2004 B1
6733533 Lozier May 2004 B1
6780497 Walter Aug 2004 B1
6852095 Ray Feb 2005 B1
6852223 Huang et al. Feb 2005 B2
6866681 Laboureau et al. Mar 2005 B2
6893465 Huang May 2005 B2
6893466 Trieu May 2005 B2
6932843 Smith et al. Aug 2005 B2
6936070 Muhanna Aug 2005 B1
6958077 Suddaby Oct 2005 B2
6969404 Ferree Nov 2005 B2
6969405 Suddaby Nov 2005 B2
6984246 Huang Jan 2006 B2
7001431 Bao et al. Feb 2006 B2
7004971 Serhan et al. Feb 2006 B2
7008427 Sevrain Mar 2006 B2
7056345 Kuslich Jun 2006 B2
7077865 Bao et al. Jul 2006 B2
7133001 Mrstik et al. Nov 2006 B2
7156861 Scribner et al. Jan 2007 B2
7156877 Lotz et al. Jan 2007 B2
7182783 Trieu Feb 2007 B2
7201751 Zucherman et al. Apr 2007 B2
7201776 Ferree et al. Apr 2007 B2
7204851 Trieu et al. Apr 2007 B2
7220282 Kuslich May 2007 B2
7267687 McGuckin et al. Sep 2007 B2
7273497 Ferree Sep 2007 B2
7297158 Jensen Nov 2007 B2
7309359 Trieu et al. Dec 2007 B2
7556650 Collins et al. Jul 2009 B2
7563284 Coppes et al. Jul 2009 B2
7618461 Trieu Nov 2009 B2
7632291 Stephens et al. Dec 2009 B2
7632294 Milbodker et al. Dec 2009 B2
7641691 Lotz et al. Jan 2010 B2
7645301 Hudgins et al. Jan 2010 B2
7713301 Bao et al. May 2010 B2
7722612 Sala et al. May 2010 B2
7731753 Reo et al. Jun 2010 B2
7766965 Bao et al. Aug 2010 B2
7789913 Collins et al. Sep 2010 B2
7799079 Hestad et al. Sep 2010 B2
7837733 Collins et al. Nov 2010 B2
7842055 Pintor et al. Nov 2010 B2
7896920 Yuksel et al. Mar 2011 B2
7931689 Hochschuler et al. Apr 2011 B2
7947079 Helm et al. May 2011 B2
7972351 Trinidad Jul 2011 B2
7993351 Worley et al. Aug 2011 B2
7993404 Trieu Aug 2011 B2
7998210 Edie et al. Aug 2011 B2
8012210 Lin et al. Sep 2011 B2
8012211 Kuslich Sep 2011 B2
8043381 Hestad et al. Oct 2011 B2
8066758 Bogert et al. Nov 2011 B2
8083800 Edie Dec 2011 B2
8092536 Ahrens et al. Jan 2012 B2
8100978 Bass Jan 2012 B2
8123808 Dewey et al. Feb 2012 B2
8133250 Parsonage et al. Mar 2012 B2
8142456 Rosqueta et al. Mar 2012 B2
8142489 Doran et al. Mar 2012 B2
8236057 Wirtel, III et al. Aug 2012 B2
8246682 Slivka et al. Aug 2012 B2
8287595 Vresilovic et al. Oct 2012 B2
8292961 Osman Oct 2012 B2
8317864 Kim Oct 2012 B2
8337556 Shaolian et al. Dec 2012 B2
8337557 Collins et al. Dec 2012 B2
8349013 Zucherman et al. Jan 2013 B2
8377131 Lin Feb 2013 B2
8377136 Simonton Feb 2013 B2
8377138 Reo et al. Feb 2013 B2
8382838 Baumgartner et al. Feb 2013 B2
8398511 Sandusky Mar 2013 B2
8403987 Reo et al. Mar 2013 B2
8419839 Shimatani Apr 2013 B2
8444694 Collins et al. May 2013 B2
8449660 Shimatani et al. May 2013 B2
8454612 Lambrecht et al. Jun 2013 B2
8460383 Wirtel, III et al. Jun 2013 B2
8480718 Protopsaltis et al. Jul 2013 B2
8540772 Osman Sep 2013 B2
8551172 Park Oct 2013 B2
8562634 Middleton Oct 2013 B2
8603171 McClellan, III et al. Dec 2013 B2
8632592 Barrall Jan 2014 B2
8636803 Hibri et al. Jan 2014 B2
8663328 Justis et al. Mar 2014 B2
8690919 Lange et al. Apr 2014 B2
8727920 Sandusky May 2014 B2
8734459 Alobaid May 2014 B1
8747475 Kuslich Jun 2014 B2
8808381 Kim et al. Aug 2014 B2
8888850 Linares Nov 2014 B2
8894563 Connors et al. Nov 2014 B2
8945223 Trieu Feb 2015 B2
8979931 Stad et al. Mar 2015 B2
9486323 Hibri et al. Nov 2016 B1
20020026244 Trieu Feb 2002 A1
20020068975 Teitelbaum et al. Jun 2002 A1
20020147497 Belef et al. Oct 2002 A1
20020151979 Lambrecht et al. Oct 2002 A1
20020198588 Armstrong et al. Dec 2002 A1
20030028251 Mathews Feb 2003 A1
20030040772 Hyodoh et al. Feb 2003 A1
20030114917 Holloway et al. Jun 2003 A1
20030153976 Cauthen et al. Aug 2003 A1
20030199979 McGuckin, Jr. Oct 2003 A1
20040092948 Stevens et al. May 2004 A1
20040106999 Mathews Jun 2004 A1
20040186471 Trieu Sep 2004 A1
20040220672 Shadduck Nov 2004 A1
20040230309 DiMauro et al. Nov 2004 A1
20050004578 Lambrecht et al. Jan 2005 A1
20050015150 Lee Jan 2005 A1
20050055099 Ku Mar 2005 A1
20050065609 Wardlaw Mar 2005 A1
20050090901 Studer Apr 2005 A1
20050113919 Cragg et al. May 2005 A1
20050119752 Williams et al. Jun 2005 A1
20050119852 Iguchi et al. Jun 2005 A1
20050137675 Dubson et al. Jun 2005 A1
20050197702 Coppes et al. Sep 2005 A1
20050251259 Suddaby Nov 2005 A1
20050278029 Trieu Dec 2005 A1
20060047296 Embry et al. Mar 2006 A1
20060149380 Lotz Jul 2006 A1
20060247780 Bert Nov 2006 A1
20060253132 Evans et al. Nov 2006 A1
20060265077 Zwirkoski Nov 2006 A1
20060293749 Hudgins et al. Dec 2006 A1
20070021835 Edidin Jan 2007 A1
20070060924 Choi Mar 2007 A1
20070073402 Vresilovic et al. Mar 2007 A1
20070093906 Hudgins et al. Apr 2007 A1
20070135921 Park Jun 2007 A1
20070150061 Trieu Jun 2007 A1
20070162135 Segal et al. Jul 2007 A1
20070162136 O'Neil et al. Jul 2007 A1
20070168031 Hudgins et al. Jul 2007 A1
20070168042 Hudgins et al. Jul 2007 A1
20070173935 O'Neil et al. Jul 2007 A1
20070173940 Hestad et al. Jul 2007 A1
20070200271 Dave Aug 2007 A1
20070213732 Khanna et al. Sep 2007 A1
20070255285 Trieu Nov 2007 A1
20070255406 Trieu Nov 2007 A1
20070265077 Tom et al. Nov 2007 A1
20070270953 Trieu Nov 2007 A1
20070288095 Wirtel et al. Dec 2007 A1
20080046082 Lee Feb 2008 A1
20080058932 Trieu et al. Mar 2008 A1
20080119943 Armstrong et al. May 2008 A1
20080132934 Reiley et al. Jun 2008 A1
20080154367 Justis et al. Jun 2008 A1
20080154368 Justis et al. Jun 2008 A1
20080154373 Protopsaltis et al. Jun 2008 A1
20080195210 Milijasevic et al. Aug 2008 A1
20080288073 Renganath et al. Nov 2008 A1
20080288074 O'Neil et al. Nov 2008 A1
20090012618 Ahrens et al. Jan 2009 A1
20090030399 Raiszadeh et al. Jan 2009 A1
20090076609 Stewart Mar 2009 A1
20090076610 Afzal Mar 2009 A1
20090082870 Osman Mar 2009 A1
20090105823 Williams et al. Apr 2009 A1
20090112221 Burke et al. Apr 2009 A1
20090112323 Hestad et al. Apr 2009 A1
20090118833 Hudgins et al. May 2009 A1
20090138053 Assell et al. May 2009 A1
20090163994 Quigley et al. Jun 2009 A1
20090222093 Liu et al. Sep 2009 A1
20090240341 Diwan et al. Sep 2009 A1
20090299476 Diwan et al. Dec 2009 A1
20100030216 Arcenio Feb 2010 A1
20100145462 Ainsworth et al. Jun 2010 A1
20100191335 Root et al. Jul 2010 A1
20100193999 Anneaux et al. Aug 2010 A1
20100256619 Teitelbaum et al. Oct 2010 A1
20100256766 Hibri et al. Oct 2010 A1
20100292798 Maestretti Nov 2010 A1
20110022089 Assell et al. Jan 2011 A1
20110093076 Reo et al. Apr 2011 A1
20110125158 Diwan et al. May 2011 A1
20110190753 Forrest Aug 2011 A1
20110196499 Boucher et al. Aug 2011 A1
20110264224 Ferree Oct 2011 A1
20110282418 Saunders et al. Nov 2011 A1
20110319996 Barrall Dec 2011 A1
20120089227 Jarzem Apr 2012 A1
20120089229 Thramann Apr 2012 A1
20120165941 Rabiner et al. Jun 2012 A1
20120277862 Tornier et al. Nov 2012 A1
20120310352 DiMauro et al. Dec 2012 A1
20120316648 Lambrecht et al. Dec 2012 A1
20130004586 Vachon et al. Jan 2013 A1
20130103155 Tornier et al. Apr 2013 A1
20130131806 Carpetner May 2013 A1
20130297026 de Villiers et al. Nov 2013 A1
20130304212 VonGunten Nov 2013 A1
20140052250 Wirtel et al. Feb 2014 A1
20140094914 Hibri et al. Apr 2014 A1
20140276832 Hibri et al. Sep 2014 A1
20140277467 Hibri et al. Sep 2014 A1
20140288656 Kuslich Sep 2014 A1
20150057752 Hibri et al. Feb 2015 A1
20160120653 Hibri et al. May 2016 A1
20160120654 Hibri et al. May 2016 A1
20170056195 Lutz et al. Mar 2017 A1
Foreign Referenced Citations (16)
Number Date Country
2468908 Jun 2003 CA
101076302 Nov 2007 CN
101448471 Jun 2009 CN
101557779 Oct 2009 CN
103099689 May 2013 CN
2005511143 Apr 2005 JP
2012513243 Jun 2012 JP
20120040309 Apr 2012 KR
WO 2001097721 Dec 2001 WO
WO 2003047472 Jun 2003 WO
WO 2006060482 Dec 2005 WO
WO 2006025815 Mar 2006 WO
WO 2006130796 Dec 2006 WO
WO 2007087404 Aug 2007 WO
WO 2014158762 Oct 2014 WO
WO 2016073587 May 2016 WO
Non-Patent Literature Citations (26)
Entry
International Search Report and Written Opinion from the International Searching Authority issued in corresponding International application No. PCT/US2019/049548 dated May 7, 2021.
Office Action from the United States Patent and Trademark Office issued in corresponding patent U.S. Appl. No. 15/958,715 dated Sep. 9, 2020.
Notice of Reasons for Rejection from the Japanese Patent Office issued in corresponding patent Application No. 2018-530671 dated Sep. 2, 2020.
Search Report from China National Intellectual Property Administration issued in corresponding Patent Application No. 201680058105X dated Apr. 23, 2020.
The First Office Action from the China National Intellectual Property Administration issued in corresponding Patent Application No. 201680058105X dated Apr. 30, 2020.
Examination Report No. 1 from IP Australia issued in corresponding Patent Application No. 2016315964 dated May 23, 2020.
First Examination Report from the Indian Patent Office issued in corresponding Application No. 8509/DELNP/2015 dated Oct. 28, 2020.
Office Action Issued in Corresponding Brazilian Patent Application No. BR112015023003-2, dated Jan. 22, 2020.
Office Action issued in Corresponding Canadian Application No. 2,906,340, dated Feb. 27, 2020.
Supplementary European Search Report issued in European Application No. 15857214.9, dated Oct. 10, 2017.
Notice of Preliminary Rejection from the Korean Intellectual Property Office in corresponding application No. 10-2015-7028728 dated Sep. 28, 2020.
International Search Report and Written Opinion for PCT/US2015/058976 dated Jan. 25, 2016.
Office Action issued in Chinese Patent Application No. 201580066464.5, dated Aug. 2, 2018. Received Aug. 22, 2018.
Non-Final Office Action issued by the United States Patent and Trademark Office in related U.S. Appl. No. 16/560,684 dated Apr. 5, 2021.
Birkenmaier et al., “Minimally Invasive Endoscopic Spinal Surgery”, www.pineuniverse.com/displayarticle.pho/article2016.html.
Examination Report No. 1 from IP Australia issued in corresponding Patent Application No. 2015343171 dated Aug. 19, 2019.
International Search Report and Written Opinion for PCT/US2015/059011, dated Feb. 15, 2016.
International Search Report and Written Opinion issued in PCT Application No. PCT/US2016/049816, dated Dec. 8, 2016.
International Search Report dated Jun. 17, 2014 for International Application No. PCT/US2014/019911, filed Mar. 3, 2014.
International Search Report dated Jun. 19, 2014 for International Application No. PCT/US2014/019887.
International Search Report dated Jun. 25, 2014 for International Application No. PCT/US2014/019957, filed Mar. 3, 2014.
Sharma et al., “Manufacturing of Doubly Curved Tubular Composite Structure: Mapping and Weave Modification,” Thermoplastic Composite Materials, 15:209-225 (May 2002).
Supplementary European Search Report issued in European Patent Application No. 16842957.9, dated Jul. 26, 2018.
Viscocliosi et al., “Beyond Total Disc: The Future of Spine Surgery,” Spine Non-Fusion, Musculoskeletal Investment Research, pp. 1-289, (May 2004).
Wu et al., “The direct effect of graft compliance mismatch per se on development of host arterial intimal hyperplasia at the anastomotic interface,” Annals of Vascular Surgery, 7(2):156-168 (Mar. 1993).
Office Action issued in Corresponding Canadian Application No. 2,966,748, dated Dec. 3, 2021.
Related Publications (1)
Number Date Country
20190247196 A1 Aug 2019 US
Provisional Applications (1)
Number Date Country
62074925 Nov 2014 US
Divisions (1)
Number Date Country
Parent 14932242 Nov 2015 US
Child 16396042 US